SEC Form 4 · accession 0001209191-18-057412
Orthofix Medical Inc. · OFIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Luke T Faulstick
Director
Period of report
Nov 2, 2018
Accepted (ET)
Nov 6, 2018 · 4:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884624
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 2, 2018 | S | 3,500 | $60.9271 | D | 7,129 | D | |
| Common StockF2 | Nov 2, 2018 | S | 650 | $61.7243 | D | 6,479 | D | |
| Common Stock | Nov 2, 2018 | M | 4,300 | $32.13 | A | 10,779 | D | |
| Common StockF3 | Nov 2, 2018 | S | 3,600 | $60.9251 | D | 7,179 | D | |
| Common StockF4 | Nov 2, 2018 | S | 700 | $61.7357 | D | 6,479 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F5 | $32.13 | Nov 2, 2018 | M | 4,300 | D | — | Sep 17, 2024 | Common Stock | 4,300 | 25,700 | D |
Explanation of responses
- F1The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.54 to $61.39, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.61 to $61.87, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.51 to $61.39, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
- F4The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.62 to $61.87, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.
- F5These stock options vest in 25% increments on each of September 17, 2015, 2016, 2017 and 2018.